Compound Q&A
What is the market or research trend for Erythromycin A Oxime (CAS: 111321-02-9)?
Answer
The market and research trends for Erythromycin A Oxime (CAS: 111321-02-9) are focused on its antimicrobial properties and its role in developing new antibiotic treatments. Research is ongoing to explore its potential in combination therapies and to address the growing issue of antibiotic resistance. Market trends indicate increasing demand in the pharmaceutical industry, particularly in the treatment of respiratory infections and other bacterial infections.
About
CAS No
111321-02-9
English Name
Erythromycin A Oxime
Molecular Formula
C37H68N2O13
Molecular Weight
748.95 g/mol
SMILES
CCC1C(C(C(C(=NO)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O
InChIKey
KYTWXIARANQMCA-ZTILBQITSA-N
Last Updated: 2025-11-11 20:48
